Back to research feed

Cardiology in the young

September 30, 2026 · via Europe PMC

Effectiveness of ivabradine in a paediatric case of cardiomyopathy secondary to a noradrenaline-producing paraganglioma.

Tanaka Y, Go K, Yoshida S.

Journal ArticleAbstract only — full text under license

AI summary — for doctors, generated from the abstract only

Ivabradine improved heart failure in a boy whose cardiomyopathy was caused by a noradrenaline-producing paraganglioma.

What was studied

Case report of a boy with heart failure and mechanical pulsus alternans unresponsive to enalapril and carvedilol.

Key findings

  • Pulsus alternans disappeared and LV contraction improved after ivabradine.
  • An abdominal paraganglioma was found.
  • Excision normalised LV contraction.

Clinical relevance

Catecholamine-induced cardiomyopathy is a rare mimic of dilated cardiomyopathy.

Who should care

Pediatric Cardiology

Limitations

A single case.

Consider catecholamine-secreting tumors in unexplained pediatric cardiomyopathy.

This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.

Abstract

A boy with heart failure and mechanical pulsus alternans was treated with enalapril malate and carvedilol; however, left ventricular contraction did not improve. After treatment with ivabradine, the pulsus alternans disappeared, and left ventricle contraction improved. Thorough evaluation revealed an abdominal paraganglioma producing noradrenaline, and excision of the tumor normalised the left ventricle contraction. Catecholamine-induced cardiomyopathy caused by paragangliomas is an extremely rare but important differential diagnosis of dilated cardiomyopathy. Thus, ivabradine is a good candidate for the treatment of heart failure, even in the presence of catecholamine-producing tumours.

DOI

10.1017/s1047951126124184

PMID

42813551

Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.

Want more like this?

Browse more from the feed. A free account unlocks the full feed, saving and communities.

Back to the research feed

Create a free account · Sign in